Literature DB >> 33068063

Thymoquinone loaded calcium alginate and polyvinyl alcohol carrier inhibits the 7,12-dimethylbenz[a]anthracene-induced hamster oral cancer via the down-regulation of PI3K/AKT/mTOR signaling pathways.

Yumei Pu1, Shiqi Hu2, Yongfeng Chen3, Qian Zhang1, Chengwan Xia1, Han Deng1, Yuxin Wang1, Qingang Hu1.   

Abstract

Oral cancer is a multifactorial cancer that affects millions of peoples worldwide. The current exploration aimed to evaluate the mechanisms that thymoquinone nanoencapsulated carrier and its effects on 7,12-Dimethylbenz[a]anthracene (DMBA) stimulated hamster buccal pouch cancer in Syrian hamster model. Nanocarrier was characterized by SEM, TEM, FTIR analysis. The incidence of tumor, and biochemicals makers was studied through standard methods. The mRNA expression level of inflammatory markers NF-κBp50, NF-κBp65, and PI3K/AKT/mTOR markers in the buccal tissues of control and experimental animals were investigated through RT-PCR analysis. In thymoquinone (TQ) loaded calcium alginate and polyvinyl alcohol carrier (TQ/Ca-alg-PVA) no squamous cell carcinogenesis developed and others moderate dysplasia revealed differentiated form of hyperplasia and keratosis. In biochemical analyses with DMBA + TQ/Ca-alg-PVA (20 mg/kg bw) orally administered hamsters showed restored the antioxidants, detoxification, xenobiotic metabolising enzymes in DMBA induced plasma and oral tissues of hamsters. Further, mRNA expression level of NF-κBp50/p65 and PI3K/AKT/mTOR were upregulated in the DMBA alone painted hamster. In contrast, these expressions were down regulated in orally TQ/Ca-alg-PVA treated experimental animals. This ability more eligible to deregulate the inflammatory and PI3K/AKT/mTOR signaling pathway that proved it suppresses anti-invasion/metastasis activity during hamster buccal pouch carcinogenesis. From this study, we recommended that TQ/Ca-alg-PVA has documented as effective chemopreventive agents, in further many molecular machineries need to study.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  DMBA; PI3K/AKT/mTOR; hamster; nanocarrier; oral cancer; thymoquinone

Year:  2020        PMID: 33068063     DOI: 10.1002/tox.23040

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  3 in total

1.  Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Yan Dong; Liyan Xue; Yan Zhang; Caiyun Liu; Yanguang Zhang; Na Jiang; Xiaoyan Ma; Fangyu Chen; Lingxia Li; Liyuan Yu; Xuefeng Liu; Shujuan Shao; Shufang Guan; Jian Zhang; Qingchun Xiao; Hui Li; Ailing Dong; Lijie Huang; Chenyang Shi; Yan Wang; Ming Fu; Ning Lv; Qimin Zhan
Journal:  J Exp Clin Cancer Res       Date:  2022-04-21

Review 2.  The applications of polysaccharides in dentistry.

Authors:  Zhijing Yang; Weiwei Liu; Huimin Liu; Rong Li; Lu Chang; Shaoning Kan; Ming Hao; Dongxu Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22

Review 3.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.